Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience

scientific article published on September 2016

Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4103/0971-4065.177207
P932PMC publication ID5015507
P698PubMed publication ID27795623

P2093author name stringN Raju
M S Uppin
K K Mukku
M Surendra
S B Raju
S Chandragiri
P2860cites workRituximab in renal transplantationQ27026434
Antibody-mediated rejection in kidney transplantation: a reviewQ35915453
Factors contributing to acute rejection in renal transplantation: the role of noncomplianceQ36167195
Antibody-mediated rejection in renal allografts: lessons from pathologyQ36910391
The spectrum of antibody-mediated renal allograft injury: implications for treatmentQ37176570
Rejection of the kidney allograftQ37798268
The Banff classification revisitedQ38067050
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.Q39904553
KDIGO clinical practice guideline for the care of kidney transplant recipientsQ39936865
Banff 07 classification of renal allograft pathology: updates and future directionsQ40121163
Antibody-mediated rejection and treatment in pediatric patients: one center's experience.Q44519214
Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.Q44533720
Rituximab as treatment for refractory kidney transplant rejectionQ44899030
Impact of rituximab therapy for treatment of acute humoral rejectionQ45361905
National conference to assess antibody-mediated rejection in solid organ transplantationQ47347260
Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.Q47862854
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejectionQ47869308
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal TransplantationQ56907959
Rituximab therapy for acute humoral rejection after kidney transplantationQ80318231
P433issue5
P921main subjectrituximabQ412323
P304page(s)317-321
P577publication date2016-09-01
P1433published inIndian Journal of NephrologyQ6020793
P1476titleRituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience
P478volume26

Reverse relations

Q41041729Rituximab use in late antibody-mediated rejectioncites workP2860

Search more.